Followers | 0 |
Posts | 1151 |
Boards Moderated | 0 |
Alias Born | 07/10/2003 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, July 17, 2004 6:26:11 PM
SARASOTA, Fla.--(BUSINESS WIRE)--June 27, 2002--DNAPrint genomics, Inc. (OTCBB:DNAP - News) announced today that the company has been invited by the British Consulate to present at an exclusive gathering for a group of UK pharmaceutical and biotech companies.
The meeting was established by the Trade Partners UK initiative of the British Consulate to promote partnerships between British Pharmaceutical/Biotech and US/Canadian Pharmacogenomics companies. The meeting will take place October 10-11 in Washington D.C.
The United Kingdom (UK) is the current, and historical home for 75% of all European biotechnology companies, including Glaxo Wellcome, SmithKline Beecham (now, GlaxoSmithKline) (NYSE:GSK - News), and Roche (SWX:RO). For more information about the Consulates efforts, please see http://www.itp.org.uk/bio2000.html.
*************************************************************
Now that some time has past since - What do you think.
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM